VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma.
Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma. J Clin Oncol. 2009 Sep 01; 27(25):4076-81.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Angiogenesis Inhibitors
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Carcinoma, Renal Cell
Chemotherapy, Adjuvant
Disease-Free Survival
Erlotinib Hydrochloride
Feasibility Studies
Female
Humans
Kaplan-Meier Estimate
Kidney Neoplasms
Male
Middle Aged
Neoadjuvant Therapy
Nephrectomy
Proportional Hazards Models
Prospective Studies
Quinazolines
Risk Assessment
Time Factors
Treatment Outcome
Wound Healing
authors with profiles
CHRISTOPHER G WOOD
PHEROZE TAMBOLI
NIZAR M TANNIR
SURENA MATIN
ERIC JONASCH
JOHN CHARLES ARAUJO
PAUL CORN